Latest News & Updates
Breaking News
20 hours ago
Simantini Singh Deo
Other trending news you may like to read
Sanofi & Regeneron’s Dupixent Secures EU Approval, Marking The First Targeted Therapy For Chronic Spontaneous Urticaria In 10 Years
EU approves Dupixent for moderate-to-severe chronic spontaneous urticaria, offering a first-line biologic option for patients uncontrolled on antihistamines.
Simantini Singh Deo
Freya Pharma Solutions Rebrands As Arletta Pharma Solutions, Signaling A New Era In Women’s Healthcare Innovation
Freya Pharma rebrands as Arletta Pharma, advancing key clinical programs and moving closer to approval for innovative therapies targeting female sexual disorders.
Simantini Singh Deo
20251128165719.png)
GENFIT Appoints Dr. Pejvack Motlagh As Chief Medical Officer To Lead Clinical Strategy In Rare Liver Diseases
GENFIT appoints Dr. Pejvack Motlagh as Chief Medical Officer to strengthen clinical leadership and advance programs in severe liver diseases.
Simantini Singh Deo
Regeneron’s Dupixent Receives European Commission Approval After Strong Phase 3 Trial Results As First-Line Targeted Therapy For Chronic Spontaneous Urticaria
EU approves Dupixent as first-line targeted therapy for chronic spontaneous urticaria, offering significant itch and hive reduction for patients 12+.
Vaibhavi M.
